Literature DB >> 132454

Alteration in intracellular sodium concentration and ouabain-sensitive ATPase in erythrocytes from hyperthyroid patients.

C H Cole, R W Waddell.   

Abstract

The activity of the ouabain-sensitive sodium-potassium-activated component of the ATP-hydrolyzing enzyme system (ouabain sensitive ATPase) was studied in the erythrocyte membranes of 10 patients with hyperthyroidism, and found to be decreased in all 10 patients. The mean ouabain-sensitive ATPase activity was 43 +/- 4 nmol Pi/mg tissue/h in the patients, compared with 69 +/- 5 nmol Pi/mg tissue/h in the erythrocyte membranes of 10 paired control subjects. The mean concentration of sodium within the erythrocytes was 10.8 +/- 0.9 nmol/liter of red blood cells in the patients and 7.2 +/- 0.3 nmol/liter of red blood cells in the controls. The decrease in ouabain-sensitive ATPase activity did not appear to be associated with a change in the ligand sensitivity of ATPase, nor was there a difference in the activity of the ouabain-insensitive component of ATPase. Serial studies to follow the effects of treatment of hyperthyroidism on red cell membrane ATPase were performed repeatedly in one of these patients. There was a significant inverse correlation between L-thyroxine (T4) and ouabain-sensitive ATPase, as both variables returned to normal. Normal erythrocyte membranes were assayed for ATPase activity in the presence of varying concentrations of L-triiodothyronine (T3) and T4, and following pre-incubation with T4. No significant effect on erythrocyte membrane ATPase was demonstrated in either series of experiments. It can be concluded from these studies that the decreased sodium efflux in the erythrocytes of patients with hyperthyroidism is associated with a decrease in the activity of the ouabain-sensitive component of ATPase in the erythrocyte membrane. The failure to reproduce this effect in vitro suggests that it does not represent a direct effect of the thyroid hormones on the mature erythrocyte membrane.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132454     DOI: 10.1210/jcem-42-6-1056

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Functionally abnormal Na+-K+ pump in erythrocytes of a morbidly obese patient.

Authors:  M DeLuise; J S Flier
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

Review 3.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

4.  Effects of isoproterenol on rubidium transport in slow- and fast-twitch muscles from euthyroid and hyperthyroid rats.

Authors:  G M Molnár; T Kovács; T Bányász
Journal:  Pflugers Arch       Date:  1986-10       Impact factor: 3.657

5.  Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.

Authors:  J T Cheng; T Kahn; D M Kaji
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

6.  Peripheral effects of thyroid hormones: alteration of intracellular Na-concentration, ouabain-sensitive Na-transport, and Na-Li countertransport in human red blood cells.

Authors:  U Sütterlin; K H Gless; K Schaz; M Hüfner; V Schütz; W Hunstein
Journal:  Klin Wochenschr       Date:  1984-06-15

7.  Na+K+ATPase activity and ouabain binding sites in erythrocytes in hyperthyroidism before and after treatment.

Authors:  C De Riva; S Chen; F Virgili; F Frigato
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

8.  In vitro effects of thyroid hormones on red blood cell Ca++-dependent ATPase activity.

Authors:  G Costante; G Sand; D Connart; D Glinoer
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

9.  Alterations in osmotic fragility of the red blood cells in hypo- and hyperthyroid patients.

Authors:  S Zahedi Asl; N Khalili Brojeni; A Ghasemi; F Faraji; M Hedayati; F Azizi
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

10.  Red cell sodium and ionic fluxes in patients with hyper- and hypothyroidism.

Authors:  Y S Yoon; K S Hong; B Y Cha; Y W Kim; K W Lee; H Y Son; S K Kang; B K Bang; H R Moon
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.